Synthetic M13 phage engagers expand CAR-T cell antigen recognition to overcome tumor heterogeneity

This work reports a bacteriophage-based engager platform that simultaneously addresses antigen heterogeneity and functional exhaustion of chimeric antigen receptor T cells in solid tumors. It enables modular antigen redirection and eliminates immune suppression to improve antitumor responses.